Published March 1, 2018 | Version v1
Dataset Open

Report: Culturing patient leukemic cells

Creators

  • 1. Structural Genomics Consortium, Princess Margaret Cancer Centre, University Health Network
  • 2. Princess Margaret Cancer Centre, University Health Network
  • 3. Structural Genomics Consortium, University of Toronto
  • 4. Princess Margaret Cancer Centre, University Health Network, University of Toronto
  • 5. Structural Genomics Consortium, Princess Margaret Cancer Centre, University Health Network, University of Toronto

Description

A summary of our culturing and immunophenotyping of primary leukemic cells from AML patients.

Notes

The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z]. This project receives funding from the Leukemia and Lymphoma Society of Canada.

Files

2-20-2018_culturing_leukemic_cells.pdf

Files (868.9 kB)

Name Size Download all
md5:8cd8f49e6888ebdeda862392f190047c
485.6 kB Download
md5:a3a83beed177956ace340ba292723ea9
383.3 kB Preview Download